Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 20, 2010Asthmatx offers first FDA-approved non-drug procedure for the treatment of severe asthma
Boston Scientific Corporation (NYSE: BSX) today announced the signing of a definitive merger agreement, under which Boston...
-
Sep 16, 2010FDA approval is based on results from the Company's landmark MADIT-CRT trial
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for...
-
Sep 14, 2010Company to present clinical data on its platinum chromium PROMUS® Element™ and TAXUS® Element™ Coronary Stent Systems
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Cardiovascular Research...
-
Sep 2, 2010
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Morgan Stanley Global Healthcare Conference on September 14th in New...
-
Aug 19, 2010
Boston Scientific Corporation (NYSE: BSX) today announced that results from studies involving the Company's Women's Health products will be...
-
Aug 11, 2010
Boston Scientific Corporation (NYSE: BSX) today announced that it has been notified by the U.S. Food and Drug Administration that all issues cited...
-
Aug 3, 2010EVOLVE trial to evaluate Company's fourth-generation SYNERGY™ drug-eluting coronary stent
Boston Scientific Corporation (NYSE: BSX) today announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess...
-
Jul 29, 2010Company now offers pain specialists the most comprehensive portfolio of SCS percutaneous leads
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration approval of two spinal cord stimulation (SCS) leads for...
-
Jul 29, 2010
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the BMO Capital Markets Healthcare Conference on August 5th in New York....
-
Jul 26, 2010Company expands market-leading family of neurovascular stents
Boston Scientific Corporation (NYSE: BSX) today announced the U.S. and European launches of the Neuroform EZ™ Stent System, its fourth-generation...